LSSIX
Price
$24.49
Change
-$0.38 (-1.53%)
Updated
Apr 16 closing price
Net Assets
1.94B
VEXRX
Price
$90.64
Change
-$1.14 (-1.24%)
Updated
Apr 16 closing price
Net Assets
19.79B
Ad is loading...

LSSIX vs VEXRX

Header iconLSSIX vs VEXRX Comparison
Open Charts LSSIX vs VEXRXBanner chart's image
Loomis Sayles Small Cap Growth Instl
Price$24.49
Change-$0.38 (-1.53%)
VolumeN/A
Net Assets1.94B
Vanguard Explorer Adm
Price$90.64
Change-$1.14 (-1.24%)
VolumeN/A
Net Assets19.79B
LSSIX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LSSIX vs. VEXRX commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSSIX is a Buy and VEXRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. LSSIX (1.94B). VEXRX pays higher dividends than LSSIX: VEXRX (0.56) vs LSSIX (0.00). LSSIX was incepted earlier than VEXRX: LSSIX (28 years) vs VEXRX (23 years). LSSIX (0.94) is less costly to investors than VEXRX (0.34). VEXRX has a lower initial minimum investment than LSSIX: VEXRX (50000) vs LSSIX (100000). LSSIX annual gain was more profitable for investors over the last year : -5.80 vs. VEXRX (-11.16). VEXRX return over 5 years is better than : 16.93 vs. LSSIX (14.50).
LSSIXVEXRXLSSIX / VEXRX
Total Expense Ratio0.940.34276%
Annual Report Gross Expense Ratio0.940.34276%
Fund Existence28 years23 years-
Gain YTD-14.477-14.104103%
Front LoadN/AN/A-
Min. Initial Investment10000050000200%
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B19.8B10%
Annual Yield % from dividends0.000.56-
Returns for 1 year-5.80-11.1652%
Returns for 3 years-6.82-11.8658%
Returns for 5 years14.5016.9386%
Returns for 10 years1.720.21836%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFLYY0.810.01
+0.99%
Air France-KLM
GMVHY7.290.03
+0.41%
ENTAIN PLC
PVCT0.10N/A
-0.83%
Provectus Biopharmaceuticals, Inc.
SCBFY27.33-0.31
-1.12%
Standard Chartered PLC
SBGSY46.37-0.62
-1.32%
Schneider Electric SE